Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Monitoring the HIV response for trans people in Europe and Central Asia.

HIV medicine·2026

Same author

On-site testing and treatment of sexually transmitted infections among female sex workers using molecular point-of-care testing integrated into harm reduction services in Madrid, Spain.

The International journal on drug policy·2023

Same author

Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain.

BMC infectious diseases·2021

Same author

Trends and predictors of linkage to HIV outpatient care following diagnosis in the era of expanded testing in England, Wales and Northern Ireland: Results of a national cohort study.

HIV medicine·2021

Same author

Healthcare delivery for HIV-positive people with tuberculosis in Europe.

HIV medicine·2020

Same author

A new health care index predicts short term mortality for TB and HIV co-infected people.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020

Same journal

Correction to 'Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system'.

HIV medicine·2026

Same journal

Ultrasound for the determination of appropriate needle length for intragluteal injection of long-acting rilpivirine-cabotegravir.

HIV medicine·2026

Same journal

History of sexually transmitted infections among mpox cases in the 2022 outbreak in Spain.

HIV medicine·2026

Same journal

Awareness and early implementation of the European AIDS Clinical Society Guidance on statin use in HIV for the primary prevention of cardiovascular disease: A cross-sectional survey of HIV clinicians in Europe.

HIV medicine·2026

Same journal

Ankle brachial index not a reliable tool for risk assessment in people with HIV.

HIV medicine·2026

Same journal

Comparison of four frailty scores to predict adverse health events and mortality in people living with HIV aged 70 years and more (ANRS EP 66 SEPTAVIH study).

HIV medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 13, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

The case for indicator condition-guided HIV screening.

J V Lazarus¹, M Hoekstra, D Raben

¹Copenhagen HIV Programme, ISIM, Copenhagen University, Copenhagen, Denmark. jla@cphiv.dk

|March 14, 2013

Summary

This summary is machine-generated.

Late diagnosis of HIV remains a significant issue in the WHO European Region. New guidance identifies clinical conditions that should prompt HIV testing to improve early detection and outcomes.

Keywords:

AIDS Europe HIV testing health care delivery indicator conditions

More Related Videos

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: May 13, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

Public Health
Infectious Diseases
Clinical Medicine

Background:

An estimated 2.5 million individuals live with HIV in the WHO European Region.
Half of these individuals are diagnosed late, leading to poorer health outcomes.
Identifying optimal clinical scenarios for HIV testing is crucial to reduce late diagnoses.

Purpose of the Study:

To establish clear clinical criteria for recommending HIV testing.
To provide guidance for healthcare professionals to avoid late HIV presentation.
To consolidate evidence on indicator conditions for HIV screening.

Main Methods:

Utilizing data and findings from the HIV Indicator Diseases across Europe Study (HIDES).
Synthesizing existing research on conditions associated with late HIV diagnosis.
Developing a comprehensive list of clinical scenarios triggering HIV testing recommendations.

Main Results:

A curated list of specific clinical conditions has been identified.
These conditions serve as indicators for recommending HIV screening.
The guidance aims to standardize and improve the rate of timely HIV diagnoses.

Conclusions:

Implementing the new guidance can facilitate earlier HIV detection.
Targeted HIV testing based on clinical indicators can reduce late diagnoses.
This approach supports improved patient management and public health strategies in the WHO European Region.